Comparing dye and gas methods to find lung segments during surgery
Part of Lungs & breathing clinical trials.
This study compares two ways doctors find the exact border between lung segments during a minimally invasive surgery. You'll receive either a safe dye (ICG) or a carbon dioxide gas method to help the surgeon see clearly, which may make surgery more precise.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 80 years old.
- You need to be scheduled for a minimally invasive lung surgery called thoracoscopic segmentectomy, which removes a small piece of your lung.
- You must have had a recent high-resolution CT scan of your chest, with a 3D reconstruction, to help plan the surgery.
- Your surgical team must confirm that your lung lesion is suitable for this type of surgery.
- You need to be able and willing to sign a consent form.
- You must not be allergic to indocyanine green (ICG), a dye used in this study, and you cannot be pregnant or breastfeeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a special imaging technique that uses a harmless dye to help surgeons see the exact boundary between healthy and diseased lung tissue during surgery to remove a small part of the lung. This could help make the surgery more precise and potentially preserve more healthy lung.
This trial tests a new way to plan and guide lung cancer surgery using a special dye that shows the tumor area during the operation. It may help surgeons remove the cancer more accurately while targeting only a small section of lung for certain early-stage patients.
This early-stage trial tests a robotic lung surgery that uses a special dye with near-infrared light to help the surgeon remove only the tumor area. If you have a small, early lung cancer, this approach may help improve accuracy while limiting how much lung is removed.
This trial tests a new way to use a dye called ICG (indocyanine green) that is inhaled like a mist. It may help doctors see and treat congenital lung malformations in children more clearly.
This trial compares two dyes used during stomach or intestine surgery to see which helps surgeons see the blood flow better. It may help decide which dye works best for safe reconnections.
This trial tests whether using special near-infrared imaging can help surgeons better guide lung tumor removal during minimally invasive or open chest surgery. It may improve how accurately the surgical area is identified during the operation.
Hear when a new Pulmonary Nodule, Solitary trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.